These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35540700)

  • 41. Phytochemical Profiling, Biological Activities, and In Silico Molecular Docking Studies of
    Hazra S; Ray AS; Das S; Das Gupta A; Rahaman CH
    Plants (Basel); 2023 Mar; 12(7):. PubMed ID: 37050122
    [No Abstract]   [Full Text] [Related]  

  • 42. Effects of Vitex trifolia L. leaf extracts and phytoconstituents on cytokine production in human U937 macrophages.
    Wee HN; Neo SY; Singh D; Yew HC; Qiu ZY; Tsai XC; How SY; Yip KC; Tan CH; Koh HL
    BMC Complement Med Ther; 2020 Mar; 20(1):91. PubMed ID: 32188443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Baohuoside I inhibits resistance to cisplatin in ovarian cancer cells by suppressing autophagy via downregulating HIF-1α/ATG5 axis.
    Zhou Y; Liu T; Wu Q; Wang H; Sun Y
    Mol Carcinog; 2023 Oct; 62(10):1474-1486. PubMed ID: 37283234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer
    Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X
    Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Reversal effect of PI-3K/Akt pathway inhibitor LY294002 on multidrug resistance of ovarian cancer cell line A2780/Taxol].
    Shi XY; Cai XJ; Lei JX; Cao FJ; Pan DF; Chen P
    Ai Zheng; 2008 Apr; 27(4):343-7. PubMed ID: 18423117
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationship between p-cofilin and cisplatin resistance in patients with ovarian cancer and the role of p-cofilin in prognosis.
    Qin Y; Li W; Long Y; Zhan Z
    Cancer Biomark; 2019; 24(4):469-475. PubMed ID: 30932883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer Cells.
    Kou J; Gao L; Ni L; Shao T; Ding J
    Mol Biotechnol; 2024 May; 66(5):1062-1070. PubMed ID: 38184808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Octreotide reverses the resistance of A2780/Pacliaxel ovarian cancer cell line to paclitaxel chemotherapy in vitro.
    Shen Y; Zhang XY; Chen X; Ren ML; Cai YL
    J Cancer Res Ther; 2016; 12(2):657-62. PubMed ID: 27461627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of microRNA 27a and its correlation with drug resistance in human ovarian cancer A2780/Taxol cells].
    Li ZM; Hu S; Xiao L; Wang J; Cai J; Yu LL; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):372-5. PubMed ID: 20646448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Study of effects of micheliolide on ovarian cancer cell lines and its mechanism].
    Qi Z; Li YH; Ding YH; Ji Q; Yang M; Gao YD
    Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):688-692. PubMed ID: 27671051
    [No Abstract]   [Full Text] [Related]  

  • 53. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM; Turchi JJ
    Cancer Res; 1999 Jul; 59(13):3077-83. PubMed ID: 10397248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway.
    Zhang W; Yu F; Wang Y; Zhang Y; Meng L; Chi Y
    Oncol Lett; 2018 Apr; 15(4):5155-5160. PubMed ID: 29552151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer.
    Lee HH; Bellat V; Law B
    PLoS One; 2017; 12(2):e0171044. PubMed ID: 28196146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
    Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
    Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides.
    Ma X; Wang S; Zhou J; Xing H; Xu G; Wang B; Chen G; Lu YP; Ma D
    Oncol Rep; 2005 Jul; 14(1):275-9. PubMed ID: 15944801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
    Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
    Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probing Antibacterial and Anticancer Potential of
    Safdar S; Shamim S; Khan M; Imran A; Khan MA; Ali Q; Han S
    Molecules; 2023 Dec; 28(24):. PubMed ID: 38138636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.
    Zhang K; Song H; Yang P; Dai X; Li Y; Wang L; Du J; Pan K; Zhang T
    Cell Prolif; 2015 Apr; 48(2):249-58. PubMed ID: 25643607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.